[ad_1]
The global image of European cannabis is changing, again. Back in 2016, there were very few North Americans interested in what was happening this side of the Atlantic. A couple of early movers, including Tilray’s Brendan Kennedy, were in London raising money and engaging policymakers. Researchers, advocacy groups, and activists made up 95% of the legal European ‘cannabis sector’. When Germany legalised medical cannabis in 2017 something changed. European cannabis, and the commercial opportunities that…
[ad_2]
Source link